Literature DB >> 20686771

Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging.

Mustafa R Bashir1, Elmar M Merkle.   

Abstract

OBJECTIVE: One of the advantages of using hepatobiliary contrast agents in liver MRI is the ability to acquire a delayed, "hepatocyte phase" dataset. This phase highlights many types of lesions as hypointense compared with the liver, because of the accumulation of contrast material in functioning hepatocytes and non-retention within most lesions.
METHOD: Increasing the flip angle of the T1-weighted pulse sequence used to acquire the hepatocyte phase is a simple parameter change that increases the contrast-to-noise ratio of focal lesions compared with the hepatic parenchyma. RESULT: This technique increases the sensitivity for detection and conspicuity of focal liver lesions.
CONCLUSION: High flip angle delayed hepatocyte phase imaging is a useful adjunct to standard enhanced MRI of the liver. It allows for better sensitivity in focal lesion detection, particularly for small lesions. Secondarily, this technique increases the conspicuity of the biliary system, which is an additional benefit of delayed imaging with hepatobiliary contrast agents.

Entities:  

Mesh:

Year:  2010        PMID: 20686771     DOI: 10.1007/s00330-010-1917-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging.

Authors:  Young Kon Kim; Young Hwan Lee; Hyo Sung Kwak; Chong Soo Kim; Young Min Han
Journal:  Eur J Radiol       Date:  2008-11-08       Impact factor: 3.528

2.  Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Authors:  Bernd B Frericks; Christoph Loddenkemper; Alexander Huppertz; Steffi Valdeig; Andrea Stroux; Marion Seja; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

Review 3.  Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.

Authors:  F Y Yao
Journal:  Am J Transplant       Date:  2008-08-22       Impact factor: 8.086

4.  Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes.

Authors:  Kevin Tri Nguyen; Alexis Laurent; Ibrahim Dagher; David A Geller; Jennifer Steel; Mark T Thomas; Michael Marvin; Kadiyala V Ravindra; Alejandro Mejia; Panagiotis Lainas; Dominique Franco; Daniel Cherqui; Joseph F Buell; T Clark Gamblin
Journal:  Ann Surg       Date:  2009-11       Impact factor: 12.969

  4 in total
  13 in total

1.  Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.

Authors:  Alex Frydrychowicz; Scott K Nagle; Sharon L D'Souza; Karl K Vigen; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-07-12       Impact factor: 4.813

Review 2.  Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.

Authors:  Francesco Agnello; Marco Dioguardi Burgio; Dario Picone; Federica Vernuccio; Giuseppe Cabibbo; Lydia Giannitrapani; Adele Taibbi; Antonino Agrusa; Tommaso Vincenzo Bartolotta; Massimo Galia; Roberto Lagalla; Massimo Midiri; Giuseppe Brancatelli
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations.

Authors:  Jin-Young Choi; Honsoul Kim; Mark Sun; Claude B Sirlin
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

4.  Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Authors:  Mustafa R Bashir; Steven R Breault; Ryan Braun; Richard K Do; Rendon C Nelson; Scott B Reeder
Journal:  Acad Radiol       Date:  2014-04-06       Impact factor: 3.173

Review 5.  Hepatobiliary MR imaging with gadolinium-based contrast agents.

Authors:  Alex Frydrychowicz; Meghan G Lubner; Jeffrey J Brown; Elmar M Merkle; Scott K Nagle; Neil M Rofsky; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-03       Impact factor: 4.813

6.  Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis.

Authors:  Alex Frydrychowicz; Andrzej R Jedynak; Frederick Kelcz; Scott K Nagle; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-05-11       Impact factor: 4.813

7.  Detecting hepatocellular carcinoma in gadoxetic-acid-enhanced hepatobiliary-phase MR imaging at 3T: comparing high and low flip angle.

Authors:  Mina Song; Hyeon Je Cho; Yun Ku Cho; Mi Young Kim; Sang Ik Noh; Soo Hyun Yang
Journal:  Jpn J Radiol       Date:  2013-10-17       Impact factor: 2.374

8.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Elmar M Merkle; Christoph J Zech; Carlo Bartolozzi; Mustafa R Bashir; Ahmed Ba-Ssalamah; Alexander Huppertz; Jeong Min Lee; Jens Ricke; Michiie Sakamoto; Claude B Sirlin; Sheng-Long Ye; Mengsu Zeng
Journal:  Eur Radiol       Date:  2015-06-13       Impact factor: 5.315

9.  Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis.

Authors:  Dahye Lee; Eun-Suk Cho; Dae Jung Kim; Joo Hee Kim; Jeong-Sik Yu; Jae-Joon Chung
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

10.  Evaluation of hypointense liver lesions during hepatobiliary phase MR imaging in normal and cirrhotic livers: is increasing flip angle reliable?

Authors:  Yu-dong Xiao; Cong Ma; Jun Liu; Hua-bing Li; Zi-shu Zhang; Shun-ke Zhou
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.